Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

See more

Veranova Devens Site Breaks Ground on ADC Facility Expansion

See more

Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA

See more

Veranova Awarded EcoVadis Bronze Rating for Sustainability Efforts

See more

Veranova Appoints Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence

See more

Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers

See more

Veranova Hosts Second Cambridge Science Day

See more

Veranova Welcomes Dr. Scott Zugel as Global VP of Analytical Research Development Operations

See more

Join us at the ADC Analytical Development Summit!

See more

Veranova Relocates Headquarters to Devens, MA

See more

Join us at World ADC, London!

See more

Veranova honors its inspiring women on International Day for Women and Girls in Science

See more

Industry Roundtable: Small-Molecule APIs

See more

Veranova Releases New Video Showcasing Extensive Technical Capabilities and Expertise

See more

Join us at Fierce JPM Week!

See more

HPAPI for Drug Development and Delivery

See more

An interview with Veranova’s CCO, Cécile Maupas and CTO, Rohtash Kumar

See more

Veranova Recognized as One of SOCMA’s 25 Companies with Industry-Leading Safety Programs

See more

Veranova announces Cécile Maupas Now Directly Responsible for Bitrex Commercial Operations, Strengthening Veranova’s Commitment to Safety and Innovation

See more

Veranova Expands Advisory Board with Appointment of Dr. Rajni Aneja and Dr. Bradley L. Pentelute

See more

Nutriband Licenses Bitrex® Brand Aversive Agent for Its Lead Product – AVERSA™ Fentanyl Transdermal Patch

See more

The Evolution of the CDMO Industry

See more

Veranova Appoints Mayya Buffington as Vice President, Chief Information Officer

See more

Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

See more

Veranova CEO, Mike Riley, discusses the transition from chemicals to CDMO

See more

Veranova Continues Strategic Expansion with the Appointment of Ryan Raymond as Vice President, Global Controller

See more

Veranova Announces New Investment to Expand ADC and Highly Potent API Capabilities at Devens, MA, Facility

See more

ADCs and their Drug Development Process

See more

An interview with Veranova’s CEO, Mike Riley

See more

Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical and Biotech Industry

See more

Harnessing the Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

See more

Veranova CEO Mike Riley Recognized in The Medicine Maker’s Power List 2024

See more

Veranova Strengthens Senior Leadership Team with Appointment of Scott Lassonde as SVP, Chief Financial Officer

See more

Veranova Celebrates International Women’s Day 2024

See more

Veranova Hosts First Annual Veranova Chemistry and Technology Meeting (VCTM)

See more

Veranova Strengthens Engineering Leadership with Appointment of Chris Holmes as Vice President, Global Engineering

See more

Introducing Veranova’s Advisory Board

See more

Veranova Strengthens Leadership Further by Welcoming Lucas Sauer-Jones as Vice President & General Manager, New England

See more

In Conversation with Mike Riley, CEO of Veranova

See more

Kishore Hotha Joins Chemistry Today’s Scientific Advisory Board

See more

Realizing The Potential of Antibody-Drug Conjugates

See more

Jose Ibietatorremendia to Join Veranova as SVP, General Counsel, and Secretary

See more

Veranova Recognized as One of SOCMA’s 12 Companies for Industry-Leading Safety Programs

See more

Veranova Expands Contract Expertise

See more

The Evolving Role of Outsourcing in Pharmaceutical Development

See more

Investing For The Future

See more

Veranova Announces Appointment of New Advisory Board

See more

Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations

See more

Veranova at CPHI Barcelona

See more

Veranova Strengthens Leadership Team: Victoria Brown Joins as SVP, Chief HR Officer

See more

Testing Innovative Analytical Waters

See more

Managing complexity with confidence: Q&A with Veranova CEO Mike Riley

See more

Veranova celebrates the 20th anniversary of Pharmorphix®

See more

Veranova celebrates first year as an independent CDMO

See more

Dr. Rohtash Kumar joins Veranova as Chief Technology Officer

See more

Solubility – meeting the challenge

See more

Veranova appoints Mike Riley as Chief Executive Officer

See more

Veranova proposes closure of Annan facility

See more

Celebrating Veranova’s women in science

See more

Veranova completes mid-scale API expansion at Edinburgh, UK facility

See more

In conversation with Niek Stapel, CEO of Veranova

See more

How can today’s CDMOs ensure they can meet tomorrow’s demands?

See more

Leading the way in Synthetic Chemistry

See more

Veranova at CPHI WW

See more

JM Health rebrands as Veranova following sale to Altaris Capital Partners

See more

Featured insights from our experts

Read more

Antibody-drug conjugate development: challenges and opportunities

By selectively delivering highly potent APIs to cancer cells, they offer a range of improved patient outcomes, including reduced side effects and higher drug tolerability.

Read more

Understanding the formation of cocrystals

Cocrystals play an increasingly vital role in drug development, with specialist techniques required to identify and develop them.

Read more

Continuous manufacturing (flow chemistry) - the future of pharmaceutical manufacturing

Continuous manufacturing offers several advantages over traditional batch manufacturing, including increased efficiency, reduced waste, and improved product quality.

Read more

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us